Cargando…
Health care costs and utilization prior to diagnosis of antineutrophil cytoplasmic antibody vasculitis in Medicare beneficiaries
BACKGROUND: Antineutrophil cytoplasmic antibody (ANCA) vasculitis (AV) is a complex group of autoimmune disorders affecting blood vessels in multiple organ systems. Delays in diagnosis are common because AV symptoms can be nonspecific and present heterogeneously. This may result in increased health...
Autores principales: | Huang, Shirley P, Li, Xintong, Cao, Binxin, Nguyen, Joehl T, Robinson, Jacob E, Derebail, Vimal K, Hogan, Susan L, Thorpe, Carolyn T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372980/ https://www.ncbi.nlm.nih.gov/pubmed/36282932 http://dx.doi.org/10.18553/jmcp.2022.28.11.1292 |
Ejemplares similares
-
Polypharmacy in US Medicare beneficiaries with antineutrophil cytoplasmic antibody vasculitis
por: Cao, Binxin, et al.
Publicado: (2023) -
Relevance of Combined Clinicopathologic Phenotype and Antineutrophil Cytoplasmic Autoantibody Serotype in the Diagnosis of Antineutrophil Cytoplasmic Autoantibody Vasculitis
por: Alba, Marco A., et al.
Publicado: (2022) -
Antineutrophilic Cytoplasmic Antibody Positive Vasculitis
Associated with Methimazole Use
por: Shikha, Deep, et al.
Publicado: (2015) -
Stress and Disease Onset in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
por: Golemati, Christina V., et al.
Publicado: (2017) -
The role of mycophenolate in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis
por: Koukoulaki, Maria, et al.
Publicado: (2019)